Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial
索拉非尼辅助治疗中高复发风险肾细胞癌：SORCE随机III期多中心试验结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.01800
Eisen, Tim; Frangou, Eleni; Oza, Bhavna; Ritchie, Alastair W S; Smith, Benjamin; Kaplan, Rick; Davis, Ian D; Stockler, Martin R; Albiges, Laurence; Escudier, Bernard; Larkin, James; Bex, Axel; Joniau, Steven; Hancock, Barry; Hermann, Gregers G; Bellmunt, Joaquim; Hodgkinson, Elizabeth; Stewart, Grant D; Barber, Jim; Brown, Janet; McMenemin, Rhona; Nathan, Paul; Pickering, Lisa M; Parmar, Mahesh K B; Meade, Angela
